Apyx Medical Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $4.31
- Today's High:
- $4.41
- Open Price:
- $4.31
- 52W Low:
- $1.31
- 52W High:
- $11.155
- Prev. Close:
- $4.38
- Volume:
- 51378
Company Statistics
- Market Cap.:
- $109.68 million
- Book Value:
- 1.214
- Revenue TTM:
- $48.72 million
- Operating Margin TTM:
- -39.66%
- Gross Profit TTM:
- $33.60 million
- Profit Margin:
- -39.28%
- Return on Assets TTM:
- -19.63%
- Return on Equity TTM:
- -39.69%
Company Profile
Apyx Medical Inc had its IPO on 1987-01-01 under the ticker symbol APYX.
The company operates in the Healthcare sector and Medical Devices industry. Apyx Medical Inc has a staff strength of 272 employees.
Stock update
Shares of Apyx Medical Inc opened at $4.31 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $4.31 - $4.41, and closed at $4.35.
This is a -0.68% slip from the previous day's closing price.
A total volume of 51,378 shares were traded at the close of the day’s session.
In the last one week, shares of Apyx Medical Inc have slipped by -3.33%.
Apyx Medical Inc's Key Ratios
Apyx Medical Inc has a market cap of $109.68 million, indicating a price to book ratio of 1.6232 and a price to sales ratio of 1.3634.
In the last 12-months Apyx Medical Inc’s revenue was $48.72 million with a gross profit of $33.60 million and an EBITDA of $-18404000. The EBITDA ratio measures Apyx Medical Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Apyx Medical Inc’s operating margin was -39.66% while its return on assets stood at -19.63% with a return of equity of -39.69%.
In Q3, Apyx Medical Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 23%.
Apyx Medical Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-0.59 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Apyx Medical Inc’s profitability.
Apyx Medical Inc stock is trading at a EV to sales ratio of 1.1112 and a EV to EBITDA ratio of -3.0173. Its price to sales ratio in the trailing 12-months stood at 1.3634.
Apyx Medical Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $55.27 million
- Total Liabilities
- $11.19 million
- Operating Cash Flow
- $-188000.00
- Capital Expenditure
- $188000
- Dividend Payout Ratio
- 0%
Apyx Medical Inc ended 2024 with $55.27 million in total assets and $0 in total liabilities. Its intangible assets were valued at $55.27 million while shareholder equity stood at $41.99 million.
Apyx Medical Inc ended 2024 with $0 in deferred long-term liabilities, $11.19 million in other current liabilities, 35000.00 in common stock, $-29686000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $14.83 million and cash and short-term investments were $14.83 million. The company’s total short-term debt was $282,000 while long-term debt stood at $0.
Apyx Medical Inc’s total current assets stands at $46.31 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $16.66 million compared to accounts payable of $2.07 million and inventory worth $12.04 million.
In 2024, Apyx Medical Inc's operating cash flow was $-188000.00 while its capital expenditure stood at $188000.
Comparatively, Apyx Medical Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $4.35
- 52-Week High
- $11.155
- 52-Week Low
- $1.31
- Analyst Target Price
- $7.75
Apyx Medical Inc stock is currently trading at $4.35 per share. It touched a 52-week high of $11.155 and a 52-week low of $11.155. Analysts tracking the stock have a 12-month average target price of $7.75.
Its 50-day moving average was $4.95 and 200-day moving average was $3.97 The short ratio stood at 13.67 indicating a short percent outstanding of 0%.
Around 1262.3% of the company’s stock are held by insiders while 5560.5% are held by institutions.
Frequently Asked Questions About Apyx Medical Inc
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market. It also develops, manufactures, and sells disposable hand pieces, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.